Cargando…
Follow-up studies in COVID-19 recovered patients - is it mandatory?
The novel Coronavirus disease 2019 (COVID-19) is an illness caused due to Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The World Health Organization (WHO) has declared this outbreak a global health emergency and as on April 24, 2020, it has spread to 213 countries, with 25,91,015 co...
Autores principales: | Balachandar, Vellingiri, Mahalaxmi, Iyer, Subramaniam, Mohandevi, Kaavya, Jayaramayya, Senthil Kumar, Nachimuthu, Laldinmawii, Gracy, Narayanasamy, Arul, Janardhana Kumar Reddy, Patur, Sivaprakash, Palanisamy, Kanchana, Sivaprakash, Vivekanandhan, Govindasamy, Cho, Ssang-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184970/ https://www.ncbi.nlm.nih.gov/pubmed/32360909 http://dx.doi.org/10.1016/j.scitotenv.2020.139021 |
Ejemplares similares
-
Mucormycosis: An opportunistic pathogen during COVID-19
por: Mahalaxmi, Iyer, et al.
Publicado: (2021) -
COVID-19: A promising cure for the global panic
por: Vellingiri, Balachandar, et al.
Publicado: (2020) -
Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice
por: Vellingiri, Balachandar, et al.
Publicado: (2020) -
COVID-19: an update on diagnostic and therapeutic approaches
por: Iyer, Mahalaxmi, et al.
Publicado: (2020) -
Mitochondrial dysfunction: A hidden trigger of autism?
por: Balachandar, Vellingiri, et al.
Publicado: (2020)